Coloplast A/S (CLPBF)
USD 112.54
(0.0%)
USD 112.54
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 48.15 Billion DKK | 37.77% |
| 2022 | 34.95 Billion DKK | 120.67% |
| 2021 | 15.84 Billion DKK | 17.35% |
| 2020 | 13.49 Billion DKK | 6.02% |
| 2019 | 12.73 Billion DKK | 8.18% |
| 2018 | 11.76 Billion DKK | -2.33% |
| 2017 | 12.05 Billion DKK | 9.48% |
| 2016 | 11 Billion DKK | 1.76% |
| 2015 | 10.81 Billion DKK | 4.22% |
| 2014 | 10.37 Billion DKK | 10.84% |
| 2013 | 9.36 Billion DKK | -7.98% |
| 2012 | 10.17 Billion DKK | 10.39% |
| 2011 | 9.21 Billion DKK | 18.62% |
| 2010 | 7.77 Billion DKK | -2.41% |
| 2009 | 7.96 Billion DKK | -0.23% |
| 2008 | 7.98 Billion DKK | 2.98% |
| 2007 | 7.75 Billion DKK | -2.91% |
| 2006 | 7.98 Billion DKK | 34.95% |
| 2005 | 5.91 Billion DKK | 4.86% |
| 2004 | 5.64 Billion DKK | 5.24% |
| 2003 | 5.36 Billion DKK | 19.4% |
| 2002 | 4.48 Billion DKK | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 48.14 Billion DKK | -0.93% |
| 2024 Q1 | 48.59 Billion DKK | 0.9% |
| 2024 Q3 | 48.58 Billion DKK | 0.91% |
| 2023 Q3 | 35.08 Billion DKK | -0.61% |
| 2023 Q1 | 35.22 Billion DKK | 0.76% |
| 2023 FY | 48.15 Billion DKK | 37.77% |
| 2023 Q4 | 48.15 Billion DKK | 37.26% |
| 2023 Q2 | 35.3 Billion DKK | 0.23% |
| 2022 Q2 | 35.17 Billion DKK | 117.26% |
| 2022 Q1 | 16.18 Billion DKK | 2.19% |
| 2022 FY | 34.95 Billion DKK | 120.67% |
| 2022 Q3 | 35.18 Billion DKK | 0.04% |
| 2022 Q4 | 34.95 Billion DKK | -0.65% |
| 2021 Q1 | 14.92 Billion DKK | 10.57% |
| 2021 FY | 15.84 Billion DKK | 17.35% |
| 2021 Q4 | 15.84 Billion DKK | 2.48% |
| 2021 Q3 | 15.45 Billion DKK | 1.37% |
| 2021 Q2 | 15.24 Billion DKK | 2.16% |
| 2020 Q4 | 13.49 Billion DKK | 1.38% |
| 2020 Q1 | 13.22 Billion DKK | 3.86% |
| 2020 Q2 | 13.52 Billion DKK | 2.31% |
| 2020 Q3 | 13.31 Billion DKK | -1.57% |
| 2020 FY | 13.49 Billion DKK | 6.02% |
| 2019 Q1 | 12.11 Billion DKK | 2.92% |
| 2019 FY | 12.73 Billion DKK | 8.18% |
| 2019 Q3 | 12.55 Billion DKK | 2.11% |
| 2019 Q4 | 12.73 Billion DKK | 1.44% |
| 2019 Q2 | 12.29 Billion DKK | 1.48% |
| 2018 Q3 | 12.66 Billion DKK | -0.66% |
| 2018 Q1 | 12.19 Billion DKK | 1.19% |
| 2018 Q4 | 11.76 Billion DKK | -7.09% |
| 2018 Q2 | 12.75 Billion DKK | 4.58% |
| 2018 FY | 11.76 Billion DKK | -2.33% |
| 2017 Q3 | 12.24 Billion DKK | -2.11% |
| 2017 Q2 | 12.51 Billion DKK | -2.89% |
| 2017 Q1 | 12.88 Billion DKK | 17.04% |
| 2017 Q4 | 12.05 Billion DKK | -1.61% |
| 2017 FY | 12.05 Billion DKK | 9.48% |
| 2016 Q4 | 11 Billion DKK | -2.42% |
| 2016 Q2 | 10.6 Billion DKK | -1.92% |
| 2016 FY | 11 Billion DKK | 1.76% |
| 2016 Q3 | 11.28 Billion DKK | 6.4% |
| 2016 Q1 | 10.81 Billion DKK | -0.06% |
| 2015 FY | 10.81 Billion DKK | 4.22% |
| 2015 Q2 | 10.62 Billion DKK | 9.9% |
| 2015 Q1 | 9.66 Billion DKK | -6.9% |
| 2015 Q3 | 9.94 Billion DKK | -6.36% |
| 2015 Q4 | 10.81 Billion DKK | 8.77% |
| 2014 Q2 | 9.27 Billion DKK | 10.41% |
| 2014 Q4 | 10.37 Billion DKK | 13.79% |
| 2014 FY | 10.37 Billion DKK | 10.84% |
| 2014 Q1 | 8.4 Billion DKK | -10.26% |
| 2014 Q3 | 9.12 Billion DKK | -1.69% |
| 2013 Q3 | 8.63 Billion DKK | -14.2% |
| 2013 FY | 9.36 Billion DKK | -7.98% |
| 2013 Q4 | 9.36 Billion DKK | 8.42% |
| 2013 Q2 | 10.06 Billion DKK | 3.0% |
| 2013 Q1 | 9.77 Billion DKK | -3.96% |
| 2012 Q3 | 9.98 Billion DKK | 7.31% |
| 2012 Q4 | 10.17 Billion DKK | 1.96% |
| 2012 FY | 10.17 Billion DKK | 10.39% |
| 2012 Q1 | 8.91 Billion DKK | -3.28% |
| 2012 Q2 | 9.3 Billion DKK | 4.31% |
| 2011 Q3 | 8.49 Billion DKK | 3.22% |
| 2011 FY | 9.21 Billion DKK | 18.62% |
| 2011 Q1 | 8.11 Billion DKK | 4.44% |
| 2011 Q2 | 8.22 Billion DKK | 1.38% |
| 2011 Q4 | 9.21 Billion DKK | 8.54% |
| 2010 Q3 | 7.91 Billion DKK | 3.83% |
| 2010 Q4 | 7.77 Billion DKK | -1.78% |
| 2010 FY | 7.77 Billion DKK | -2.41% |
| 2010 Q2 | 7.62 Billion DKK | 0.99% |
| 2010 Q1 | 7.54 Billion DKK | -5.25% |
| 2009 FY | 7.96 Billion DKK | -0.23% |
| 2009 Q4 | 7.96 Billion DKK | 0.0% |
| 2008 FY | 7.98 Billion DKK | 2.98% |
| 2007 FY | 7.75 Billion DKK | -2.91% |
| 2006 FY | 7.98 Billion DKK | 34.95% |
| 2005 FY | 5.91 Billion DKK | 4.86% |
| 2004 FY | 5.64 Billion DKK | 5.24% |
| 2003 FY | 5.36 Billion DKK | 19.4% |
| 2002 FY | 4.48 Billion DKK | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.83 Million USD | -2619999.453% |
| Ansell Limited | 3.23 Billion USD | -1387.982% |
| Ansell Limited | 3.24 Billion USD | -1385.197% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 488.98 Million USD | -9748.696% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 300.36 Thousand USD | -16033552.726% |
| Psykey, Inc. | 1.72 Million USD | -2787911.764% |
| ConvaTec Group Plc | 3.7 Billion USD | -1198.627% |
| ConvaTec Group Plc | 3.71 Billion USD | -1196.793% |
| Encision Inc. | 3.81 Million USD | -1263678.251% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 651.88 Thousand USD | -7387598.061% |
| LifePoint, Inc. | 8.8 Million USD | -546591.624% |
| Medite Cancer Diagnostics, Inc. | 15.95 Million USD | -301723.765% |
| Paradigm Medical Industries, Inc. | 895 Thousand USD | -5380793.855% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 5.48 Million USD | -877266.055% |
| Reflect Scientific, Inc. | 2.66 Million USD | -1804349.244% |
| SmileDirectClub, Inc. | 597.06 Million USD | -7965.983% |
| Sector 10, Inc. | 1000.00 USD | -4815899900.0% |
| Shandong Weigao Group Medical Polymer Company Limited | 4.74 Billion USD | -914.683% |
| SheerVision, Inc. | 837.56 Thousand USD | -5749782.099% |
| United Health Products, Inc. | 284.64 Thousand USD | -16918988.121% |
| Vasamed, Inc. | 1.6 Million USD | -3009380.435% |
| Wearable Health Solutions, Inc. | 223.17 Thousand USD | -21579123.293% |
| Yubo International Biotech Limited | 2.34 Million USD | -2050483.53% |